Market Cap 356,000.00
Revenue (ttm) 0.00
Net Income (ttm) -8.46M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.11
Volume 400
Avg Vol 6,252
Day's Range N/A - N/A
Shares Out 5.72M
Stochastic %K 3%
Beta 2.01
Analysts Strong Buy
Price Target N/A

Company Profile

Altamira Therapeutics Ltd. operates as a preclinical-stage biopharmaceutical company in Switzerland, Australia, the United States, and Europe. The company develops and supplies peptide-based nanoparticle technologies for efficient RNA delivery to extrahepatic tissues through xPhore platform; and offers Bentrio, a drug-free nasal spray for protection against airborne viruses and allergens It is also developing AM-401 for the treatment of KRAS driven cancer; AM-411 for the treatment of rheumatoid...

Industry: Biotechnology
Sector: Healthcare
Phone: 441 295 5950
Address:
Clarendon House, 2 Church Street, Hamilton, Bermuda
Cashflow62
Cashflow62 Jun. 11 at 1:10 PM
$CYTOF https://www.otcmarkets.com/stock/CYTOF/news/Altamira-Therapeutics-to-Present-at-Formulation-and-Delivery-Europe-Conference?id=524158
0 · Reply
StocktwitsEarnings
StocktwitsEarnings Mar. 31 at 3:02 PM
$CYTOF Q2 '25 Earnings Results & Recap Altamira Therapeutics reported a net loss of $3M for 2025, an improvement from $8.5M in the prior year, with operating loss decreasing to $4.4M and loss per share at $0.55.
0 · Reply
StocktwitsEarnings
StocktwitsEarnings Mar. 31 at 3:02 PM
$CYTOF Q2 '25 Earnings Results & Recap Altamira expects its operating expenses to decrease significantly in 2026, following the planned spin-off of its ATAG subsidiary and termination of US SEC reporting duties, with updated guidance to follow.
0 · Reply
Cashflow62
Cashflow62 Feb. 13 at 2:02 PM
$CYTOF Altamira Therapeutics Announces Allowance of Japanese Patent Application Covering Bentrio Nasal Spray.
0 · Reply
Cashflow62
Cashflow62 Jan. 23 at 2:12 PM
$CYTOF https://finance.yahoo.com/news/altamira-therapeutics-present-mrna-based-140000849.html
0 · Reply
Cashflow62
Cashflow62 Jan. 9 at 4:16 PM
$CYTOF Best bid in months......
1 · Reply
Cashflow62
Cashflow62 Dec. 19 at 2:31 PM
$CYTOF Altamira Therapeutics Announces Market Approval of Bentrio Nasal Spray in China.....news out.
0 · Reply
stefano93
stefano93 Dec. 8 at 7:26 AM
$CYTOF still not bankrupt? Damn.
0 · Reply
Cashflow62
Cashflow62 Nov. 20 at 2:57 PM
$CYTOF https://finance.yahoo.com/news/altamira-therapeutics-announces-certification-bentrio-140000373.html
0 · Reply
Cashflow62
Cashflow62 Nov. 3 at 2:34 PM
$CYTOF Altamira Therapeutics Announces Successful Nanoparticle-Based Delivery of DNA Molecules 11/03/2025
0 · Reply
Latest News on CYTOF
No data available.
Cashflow62
Cashflow62 Jun. 11 at 1:10 PM
$CYTOF https://www.otcmarkets.com/stock/CYTOF/news/Altamira-Therapeutics-to-Present-at-Formulation-and-Delivery-Europe-Conference?id=524158
0 · Reply
StocktwitsEarnings
StocktwitsEarnings Mar. 31 at 3:02 PM
$CYTOF Q2 '25 Earnings Results & Recap Altamira Therapeutics reported a net loss of $3M for 2025, an improvement from $8.5M in the prior year, with operating loss decreasing to $4.4M and loss per share at $0.55.
0 · Reply
StocktwitsEarnings
StocktwitsEarnings Mar. 31 at 3:02 PM
$CYTOF Q2 '25 Earnings Results & Recap Altamira expects its operating expenses to decrease significantly in 2026, following the planned spin-off of its ATAG subsidiary and termination of US SEC reporting duties, with updated guidance to follow.
0 · Reply
Cashflow62
Cashflow62 Feb. 13 at 2:02 PM
$CYTOF Altamira Therapeutics Announces Allowance of Japanese Patent Application Covering Bentrio Nasal Spray.
0 · Reply
Cashflow62
Cashflow62 Jan. 23 at 2:12 PM
$CYTOF https://finance.yahoo.com/news/altamira-therapeutics-present-mrna-based-140000849.html
0 · Reply
Cashflow62
Cashflow62 Jan. 9 at 4:16 PM
$CYTOF Best bid in months......
1 · Reply
Cashflow62
Cashflow62 Dec. 19 at 2:31 PM
$CYTOF Altamira Therapeutics Announces Market Approval of Bentrio Nasal Spray in China.....news out.
0 · Reply
stefano93
stefano93 Dec. 8 at 7:26 AM
$CYTOF still not bankrupt? Damn.
0 · Reply
Cashflow62
Cashflow62 Nov. 20 at 2:57 PM
$CYTOF https://finance.yahoo.com/news/altamira-therapeutics-announces-certification-bentrio-140000373.html
0 · Reply
Cashflow62
Cashflow62 Nov. 3 at 2:34 PM
$CYTOF Altamira Therapeutics Announces Successful Nanoparticle-Based Delivery of DNA Molecules 11/03/2025
0 · Reply
Cashflow62
Cashflow62 Oct. 30 at 2:06 PM
$CYTOF We need a huge trade to get this jolted back to life. Should have an update next 30-45 days I would think.
0 · Reply
AlphaTuna
AlphaTuna Oct. 25 at 4:16 PM
Lowest Volume Rated General Stocks Per 10/24/2025’s Close: 1 – $BARUF 2 – $AIEV 3 – $CVALF 4 – $DYNR 5 – $LUD 6 – $CYTOF 7 – $TRBMF 8 – $KPEA 9 – $FNBT 10 – $UOKA https://optimizedvalue.xyz/daily-voltech-stock-etf-volume-technical-ratings-10-24-2025/
0 · Reply
Cashflow62
Cashflow62 Oct. 17 at 5:30 PM
$CYTOF little juice today.
0 · Reply
smartmoney43
smartmoney43 Sep. 30 at 7:16 PM
$CYTOF looks interesting
1 · Reply
Cashflow62
Cashflow62 Sep. 12 at 1:48 PM
$CYTOF One day some of you will come back here and will be like, "what just happened....."
2 · Reply
Cashflow62
Cashflow62 Aug. 29 at 1:59 PM
$CYTOF The call was fine. Let's see what happens next Q.
1 · Reply
sirspanky
sirspanky Aug. 20 at 5:20 PM
$HCTI 🚨 Chart Watchers & Dip Hunters 🚨 Bear Trap set Yesterday’s pullback tagged $HCTI’s long-standing trendline perfectly. Today’s red market dragged us slightly under, but look closer — price is already pressing back to reclaim it. This trendline has been respected for months, and every prior touch has sparked major rallies (think sub-$0.02 ➝ $0.08 run). What we’re seeing smells like a classic bear trap — market-wide liquidity exit drags everything down, weak hands fold, but the setup only gets stronger. 📈 👉 Fundamentals back it up: P/S still way below sector averages (deeply undervalued vs peers). Upcoming catalysts: SecureKloud award (Aug 22) + Nasdaq compliance deadline (Aug 28). Proven buyer defense at this level — trendline history doesn’t lie. If this snaps back above the line, it could be the launchpad for the next leg. Just like we saw with $CYTOF and $SNTI bouncing off long-term channels, the setup is undeniable. Eyes up, this is one to talk about.
0 · Reply
Cashflow62
Cashflow62 Jul. 15 at 1:10 PM
$CYTOF Lucky break folks: "Altamira Therapeutics Announces Allowance of Japanese Patent Application Covering Intranasal Betahistine....." News just came out.
0 · Reply
Jimbo0119
Jimbo0119 Jul. 9 at 6:49 PM
$CYTOF lol finally year later i get into my etrade, yep sitting at a average of about 6.35 , 150 shares .... come pick ne up
2 · Reply